Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 532.20M | £ 240.90M | £ 655.90M | £ 744.10M | £ 899.00M |
Total Assets | £ 15.14B | £ 14.44B | £ 14.44B | £ 14.18B | £ 14.51B |
Total Debt | £ 8.26B | £ 7.98B | £ 8.46B | £ 8.45B | £ 8.95B |
Net Debt | £ 7.73B | £ 7.74B | £ 7.81B | £ 7.71B | £ 8.05B |
Total Liabilities | £ 12.02B | £ 11.48B | £ 11.72B | £ 11.15B | £ 11.68B |
Stockholders Equity | £ 3.12B | £ 2.96B | £ 2.72B | £ 3.03B | £ 2.83B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |